Observational Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Sep 28, 2016; 22(36): 8211-8218
Published online Sep 28, 2016. doi: 10.3748/wjg.v22.i36.8211
Figure 4
Figure 4 Outcomes of follow-up patient subset. Clinical outcomes in the follow-up subgroup according to FC result. FC: Fecal calprotectin; IBD: Inflammatory bowel disease.